These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32153734)

  • 41. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
    Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
    Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimizing the Procedure to Manufacture Clinical-Grade NK Cells for Adoptive Immunotherapy.
    Fernández A; Navarro-Zapata A; Escudero A; Matamala N; Ruz-Caracuel B; Mirones I; Pernas A; Cobo M; Casado G; Lanzarot D; Rodríguez-Antolín C; Vela M; Ferreras C; Mestre C; Viejo A; Leivas A; Martínez J; Fernández L; Pérez-Martínez A
    Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmenting the expression of NKp44 molecule and the natural killer activity in peripheral blood mononuclear cells from patients with malignant colorectal carcinoma.
    Sheikhi A; Saadati K; Jafarzadeh A; Karimi H; Mousavinasab N
    Drug Res (Stuttg); 2014 Jun; 64(6):281-6. PubMed ID: 24154937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.
    Phan MT; Lee SH; Kim SK; Cho D
    Methods Mol Biol; 2016; 1441():167-74. PubMed ID: 27177665
    [TBL] [Abstract][Full Text] [Related]  

  • 45. X-ray as Irradiation Alternative for K562 Feeder Cell Inactivation in Human Natural Killer Cell Expansion.
    Kim GH; Dang HN; Phan MT; Kweon SH; Chun S; Cho D
    Anticancer Res; 2018 Oct; 38(10):5767-5772. PubMed ID: 30275198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience.
    Rezaeifard S; Heike Y; Masuyama JI; Rezvani A; Vojdani R; Erfani N
    Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):233-243. PubMed ID: 33904681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.
    Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
    Hum Immunol; 2001 Oct; 62(10):1092-8. PubMed ID: 11600215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.
    Lee DY; Kim Y; Park JS; Choi JU; Jeong HG; Park CH
    Anticancer Res; 2023 Sep; 43(9):3897-3904. PubMed ID: 37648291
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
    Wu Z; Xu Y
    J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function.
    Satwani P; van de Ven C; Ayello J; Cairo D; Simpson LL; Baxi L; Cairo MS
    Cytotherapy; 2011 Jul; 13(6):730-8. PubMed ID: 21413839
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine-induced memory-like natural killer cells have enhanced function, proliferation, and in vivo expansion against ovarian cancer cells.
    Uppendahl LD; Felices M; Bendzick L; Ryan C; Kodal B; Hinderlie P; Boylan KLM; Skubitz APN; Miller JS; Geller MA
    Gynecol Oncol; 2019 Apr; 153(1):149-157. PubMed ID: 30658847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.
    Terunuma H
    J Stem Cells Regen Med; 2012; 8(3):205-6. PubMed ID: 24693200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Selective expansion of human natural killer cells].
    Peng BG; Liang LJ; He Q; Li J; Lu MD
    Ai Zheng; 2005 Oct; 24(10):1287-9. PubMed ID: 16219151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro modulation of natural killer activity of human peripheral blood mononuclear cells against prostate tumor cell line.
    Sheikhi A; Saadati K; Salmani R; Yahaghi N; Sheikhi A; Siemens DR
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):700-8. PubMed ID: 21425925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of a novel natural killer cell line with distinct immunostimulatory and proliferative potential as an alternative platform for cancer immunotherapy.
    Yang HG; Kang MC; Kim TY; Hwang I; Jin HT; Sung YC; Eom KS; Kim SW
    J Immunother Cancer; 2019 May; 7(1):138. PubMed ID: 31126350
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer.
    Oikawa T; Kawai K; Ishiwata I; Ohno T; Akaza H
    BJU Int; 2003 Dec; 92(9):1009-15. PubMed ID: 14632866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of Dasatinib on the Expansion, Subsets, Receptor Expression and Cytotoxic Function of NK Cells in Vitro].
    Sheng LX; Wang JP; Lai YL; Wu H; Sun YC; Zhou M; Ouyang GF; Huang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1762-1768. PubMed ID: 33067987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.